Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/112881
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Córdoba-Lanús, Elizabeth | en_US |
dc.contributor.author | García Pérez, Omar | en_US |
dc.contributor.author | Cazorla-Rivero, Sara | en_US |
dc.contributor.author | Rodríguez Esparragón, Francisco Javier | en_US |
dc.contributor.author | Piñero, José Enrique | en_US |
dc.contributor.author | Clavo, Bernardino | en_US |
dc.contributor.author | Lorenzo Morales, Jacob | en_US |
dc.date.accessioned | 2021-12-10T09:01:16Z | - |
dc.date.available | 2021-12-10T09:01:16Z | - |
dc.date.issued | 2021 | en_US |
dc.identifier.issn | 1471-2334 | en_US |
dc.identifier.other | Scopus | - |
dc.identifier.uri | http://hdl.handle.net/10553/112881 | - |
dc.description.abstract | Background: SARS-CoV-2 stability and infection persistence has been studied on different surfaces, but scarce data exist related to personal protective equipment (PPE), moreover using realist viral loads for infection. Due to the importance for adequate PPE management to avoid risk of virus infection, RNA stability was evaluated on PPE. Methods: Persistence of SARS-CoV-2 infection and detection of genomic RNA in PPE (gowns and face masks) were determined by in-vitro assays and RT-qPCR, respectively. Samples were infected with a clinical sample positive for SARS-CoV-2 (Clin-Inf), and with a heat-inactivated SARS-CoV-2 strain sample (Str-Inf) as a control. Results: PPE samples infected with Clin-Inf were positive for the 3 viral genes on gowns up to 5 days post-infection, whereas these overall genes were detected up to 30 days in the case of face masks. However, gowns and FFP2 masks samples contaminated with Clin-Inf showed a cytopathic effect over VERO cells up to 5–7 days post-infection. Conclusions: SARS-CoV-2 RNA was detected on different PPE materials for 5 to 30 days, but PPE contaminated with the virus was infectious up to 5–7 days. These findings demonstrate the need to improve PPE management and to formulate strategies to introduce viricidal compounds in PPE fabrics. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | BMC Infectious Diseases | en_US |
dc.source | BMC Infectious Diseases [EISSN 1471-2334], v. 21 (1), 1169, (Diciembre 2021) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320505 Enfermedades infecciosas | en_US |
dc.subject.other | Covid-19 | en_US |
dc.subject.other | Face Masks | en_US |
dc.subject.other | Personal Protective Equipment | en_US |
dc.subject.other | PPE | en_US |
dc.subject.other | RNA | en_US |
dc.subject.other | SARS-CoV-2 | en_US |
dc.title | Persistence of SARS-CoV-2 infection on personal protective equipment (PPE) | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1186/s12879-021-06861-7 | en_US |
dc.identifier.scopus | 85119481368 | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.authorscopusid | 6505929755 | - |
dc.contributor.authorscopusid | 57311845700 | - |
dc.contributor.authorscopusid | 57194405758 | - |
dc.contributor.authorscopusid | 6603262370 | - |
dc.contributor.authorscopusid | 7006711532 | - |
dc.contributor.authorscopusid | 57190093030 | - |
dc.contributor.authorscopusid | 6505827960 | - |
dc.identifier.eissn | 1471-2334 | - |
dc.identifier.issue | 1 | - |
dc.relation.volume | 21 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.description.numberofpages | 6 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Diciembre 2021 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 1,042 | |
dc.description.jcr | 3,667 | |
dc.description.sjrq | Q2 | |
dc.description.jcrq | Q3 | |
dc.description.scie | SCIE | |
dc.description.miaricds | 10,8 | |
item.fulltext | Con texto completo | - |
item.grantfulltext | open | - |
crisitem.author.dept | GIR IUSA-ONEHEALTH 5: Reproducción Animal, Oncología y Anestesiología Comparadas | - |
crisitem.author.dept | IU de Sanidad Animal y Seguridad Alimentaria | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.orcid | 0000-0003-1663-3673 | - |
crisitem.author.orcid | 0000-0003-2522-1064 | - |
crisitem.author.parentorg | IU de Sanidad Animal y Seguridad Alimentaria | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Rodríguez Esparragón,Francisco Javier | - |
crisitem.author.fullName | Clavo Varas,Bernardino | - |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.